We are live on ! Find out more

Large Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
FMS icon
76
Fresenius Medical Care
FMS
$13.4B
$13.4B $24.86 0%
ELAN icon
77
Elanco Animal Health
ELAN
$13.2B
$13.2B $26.39 0%
ALGN icon
78
Align Technology
ALGN
$12.9B
$12.9B $180.08 0%
BAX icon
79
Baxter International
BAX
$12.8B
$12.8B $24.77 0%
RVTY icon
80
Revvity
RVTY
$12.6B
$12.6B $113.37 0%
MDGL icon
81
Madrigal Pharmaceuticals
MDGL
$12.6B
$12.6B $546.88 0%
PEN icon
82
Penumbra
PEN
$12.6B
$12.6B $320.13 0%
ARWR icon
83
Arrowhead Research
ARWR
$12.1B
$12.1B $86.22 0%
BMRN icon
84
BioMarin Pharmaceuticals
BMRN
$11.9B
$11.9B $61.37 0%
PODD icon
85
Insulet
PODD
$11.8B
$11.8B $170.62 0%
AXSM icon
86
Axsome Therapeutics
AXSM
$11.7B
$11.7B $227.42 0%
CRL icon
87
Charles River Laboratories
CRL
$11.3B
$11.3B $234.80 0%
EHC icon
88
Encompass Health
EHC
$11.3B
$11.3B $113.80 0%
TECH icon
89
Bio-Techne
TECH
$11.2B
$11.2B $72.03 0%
GMED icon
90
Globus Medical
GMED
$11.1B
$11.1B $81.42 0%
KRYS icon
91
Krystal Biotech
KRYS
$10.7B
$10.7B $363.28 0%
CYTK icon
92
Cytokinetics
CYTK
$10.6B
$10.6B $78.39 0%
ENSG icon
93
The Ensign Group
ENSG
$10.6B
$10.6B $181.89 0%
MOH icon
94
Molina Healthcare
MOH
$10.4B
$10.4B $199.02 0%
ABVX
95
Abivax
ABVX
$10.4B
$10.4B $118.84 0%
SMMT icon
96
Summit Therapeutics
SMMT
$10.2B
$10.2B $12.80 0%
UHS icon
97
Universal Health Services
UHS
$10.2B
$10.2B $168.16 0%
APGE icon
98
Apogee Therapeutics
APGE
$10.1B
$10.1B $134.20 0%
1 2 3
4

Large Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 98 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.05T.

The largest by market cap are Abbott (ABT) at $187B, Gilead Sciences (GILD) at $165B and Pfizer (PFE) at $143B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $4.05T across 98 stocks.
  • Large Cap: market cap between $10B and $200B.
  • Largest constituent: Abbott (ABT), $187B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.